Tag: Anticoagulants
Better Outcomes for Cardiology Care in Newly Diagnosed A-Fib
Reduction in stroke, death; increase in hospitalization for AF/SVT, MI
VKA Monotherapy Linked to Reduced MI, Stroke Risk in A-Fib
Vitamin K antagonist + acetylsalicylic acid dual therapy associated with increased bleeding risk
Value of Prolonged DAPT Varies With DAPT Score in PCI Patients
Reduced risk for ischemic events in patients with high scores receiving paclitaxel-eluting stents
Antiplatelet Bleeding Risk Higher Than Expected for Older Patients
Research suggests proton-pump inhibitors should be co-prescribed in patients age 75+ years
Many Taking NOACs for A-Fib May Not Be Getting Right Dose
Study of newer medications finds 16 percent receive too much or too little
Model Predicts Acute GI Bleeding in Anticoagulated Patients
New scoring model includes five factors predictive of GI bleeding in patients taking oral anticoagulants
Distinct Maternal, Fetal Risks for Anticoagulants in Pregnancy
VKA, LMWH tied to lowest risk of adverse maternal, fetal outcomes, respectively
Restarting Anticoagulation in Certain VTE Cases Cost-Effective
Treating patients with predicted VTE risk of 17.5 percent or more may be cost-effective
Risk Up for Triple Tx Versus DAPT in DES Implantation With A-Fib
Findings for patients with atrial fibrillation who underwent PCI with drug-eluting stents
Similar Outcomes for Bivalirudin, Heparin in STEMI With PCI
No significant difference in rate of composite end point of death, myocardial infarction, or stroke
